Regulation of Pharmaceuticals: A Global Perspective
It is incumbent upon FDA to engage industry, its international counterparts and stakeholders to meet the challenges of a global market place. You have a unique opportunity to participate in a pharmaceutical conference that will bring together top level speakers from the FDA Office of the Commissioner, CDER, the FDA Northeast Regional Office(site of the conference) and industry. There will be ample opportunity for O&A and net working throughout the 2 1/2 day conference. The $500 registration fee includes continental breakfast and lunch. We welcome your participation and support for this timely and informative pharmaceutical conference.
June 6-8, 2012
Hear about the latest regulatory, scientific, technical, policy and legal developments. Our distinguished speakers include:
 |
 |
 |
 |
 |
 |
|---|---|---|---|---|---|
Murray M. Lumpkin, M.D., M.Sc.,Commissioner’s Senior Advisor and Representative for Global Issues |
Robert B. Clark,Vice President, Worldwide Regulatory Strategy US Pfizer Inc. |
John M. Taylor,Counselor to the Commissioner, Office of the Commissioner, FDA |
Brett Duersch, Ph.D.,Principal Analytical Chemist Global Science Technology and Commercialization, Merck and Co |
Vicki Seyfert-Margolis, Ph.D.,Senior Advisor for Science Innovation and Policy, Office of the Chief Scientist, FDA |
Mike Saleh, Director, Global Chemistry, Manufacturing and Controls |
For complete speaker list and additional information see Agenda
Register Online or by phone call 718-262-2790
